Newron announces US initiation of its ENIGMA-TRS 2 Phase III global study of evenamide for patients with treatment-resistant ...

Newron Pharmaceuticals SpA ( ($CH:NWRN) ) just unveiled an announcement. Newron Pharmaceuticals has announced the US launch of its global Phase ...

A woman on clozapine develops severe gastrointestinal hypomotility that progresses to toxic megacolon and multiorgan failure, ...

Newron Pharmaceuticals (SWX:NWRN) just kicked off its ENIGMA TRS 2 Phase III trial in the US, a key late stage step for Evenamide in treatment resistant schizophrenia after securing FDA and IRB ...

Overall, Contreras underscored that combining predictive analytics, AI-driven modeling, and digital monitoring can help ...

One of two women stabbed in an attack at the Australian National University two years ago tells the ACT Supreme Court she ...

Introduction Prescribing high-dose antipsychotics is typically reserved for individuals with treatment-resistant severe ...

In this Perspective, Williamson et al. argue for the integration of climate-aware competencies into mental health training to better prepare professionals for the challenges posed by the climate ...

Alto Neuroscience, Inc.'s innovative approach to CNS disorder treatment and 2026 clinical milestones. Click here to find out why ANRO stock is a Buy.

LOS ANGELES, Dec 3 (Reuters) - Ketamine, the powerful sedative that caused actor Matthew Perry's 2023 drug overdose death, ...

A NSW court is told heard Milenko Snjegota had limited capacity for reason when he allegedly murdered his 74-year-old father in their home near Wollongong.

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients worldwide, today announced encouraging ...